Are Acadia Pharmaceuticals Inc(ACAD), Box Inc(BOX) and Neuralstem Inc(CUR) Worth Investing In At This Time?

Posted by Saimoon March 13, 2015 0 Comment 1274 views


New York, NY – GDP INSIDER  –  03/13/2015.

This article discusses three companies: Acadia Pharmaceuticals Inc(NASDAQ:ACAD), Box Inc(NYSE:BOX) and Neuralstem Inc(NYSEMKT:CUR)

Acadia Pharmaceuticals Inc(NASDAQ:ACAD) closed down 22.21% or $9.94 at $24.82 yesterday, on very heavy trading of 15.279 million shares compared to its three month average trading volume of 1.532 million. The drop came after the company announced that it was going to postpone filing for FDA approval on its new drug Nuplazid until later this year, instead of in the current quarter as originally planned.  This, combined with the retirement of the current CEO, removed most of the gains that the company has made in the last month. Given the fluid situation it is better to hold than buy.

Can Acadia Pharmaceuticals Inc Regain Today’s Losses? Take A Closer Look With Our Free ACAD Analysis.

Box Inc(NYSE:BOX) took a sharp tumble yesterday dropping 11.35% or $2.33 to close at $18.20 on higher than average trading volume of 6.828 million shares. The sell off began after the cloud company announced its fourth quarter and full year financial results, which were an unexpectedly large diluted loss of $1.65 per share, compared to the market consensus estimate of $1.17. Box Inc also announced that the loss making situation is likely to continue as its revenue growth is slower than expected. With no good news on the horizon it is better to sell at this time.

Is There A Silver Lining To This Cloud? Delve Into The Details With Free BOX Analysis

Neuralstem, Inc.(NYSEMKT:CUR) plummeted 36.63% or $1.37 yesterday, to close at $2.37 on very heavy trading of 11.289 million shares compared to its three month average trading volume of 0.971 million. This came after the human stem cell research and development company announced the latest results from its phase II study of NSI-566, which were resoundingly disparaged by the scientific community as overly optimistic, as they cherry picked the best results rather than presenting a true picture. Even with its RSI now at 23.58, without market confidence it will struggle to recover, so better to sell than hold.

Is Neuralstem Inc Still Worth Taking A Chance On? Click Here For Free CUR Analysis.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.


Write Your Comment